ADC Therapeutics S.A. (NYSE:ADCT) Q1 2026 Earnings Call Transcript May 4, 2026
ADC Therapeutics S.A. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.19.
Operator: Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics Q1 2026 Earnings Conference Call. [Operator Instructions] This call is being recorded on Monday, May 4, 2026. I would now like to turn the conference over to Nicole Riley, Head of Investor Relations and Corporate...
